financetom
Business
financetom
/
Business
/
Atmus Filtration Technologies' Q3 Adjusted Earnings, Revenue Rise; Updates Full Year 2025 Guidance
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Atmus Filtration Technologies' Q3 Adjusted Earnings, Revenue Rise; Updates Full Year 2025 Guidance
Nov 7, 2025 4:46 AM

07:26 AM EST, 11/07/2025 (MT Newswires) -- Atmus Filtration Technologies ( ATMU ) reported Q3 adjusted earnings Friday of $0.69 per diluted share, compared with $0.61 a year earlier.

Two analysts polled by FactSet expected $0.59.

Revenue for the quarter ended Sept. 30 was $447.7 million, compared with $403.7 million a year earlier.

Analysts surveyed by FactSet expected $414.9 million.

For 2025, the company expects adjusted EPS of $2.50 to $2.65 on revenue of $1.72 billion to $1.75 billion. This compares with prior estimate of adjusted EPS of $2.40 to $2.60 on revenue of $1.69 billion to $1.74 billion. Analysts polled by FactSet expect $2.46 on sales of $1.71 billion.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Avid Bioservices' Waiting Period for Acquisition by GHO, Ampersand Expires
Avid Bioservices' Waiting Period for Acquisition by GHO, Ampersand Expires
Dec 30, 2024
09:47 AM EST, 12/30/2024 (MT Newswires) -- Avid Bioservices ( CDMO ) said Monday that the required waiting period for its acquisition by GHO Capital Partners and Ampersand Capital Partners has expired. The company said the acquisition is on track to close in Q1 of 2025. Price: 12.31, Change: +0.07, Percent Change: +0.57 ...
FibroBiologics Files Secondary Stock Shelf
FibroBiologics Files Secondary Stock Shelf
Dec 30, 2024
09:51 AM EST, 12/30/2024 (MT Newswires) -- FibroBiologics ( FBLG ) filed a registration statement Monday covering the potential resale of up to about 41.3 million of its shares from time to time by a selling stockholder. The company said it will not receive any proceeds from such sale. FibroBiologics ( FBLG ) shares fell 3% in early trading. Price:...
Adentra Gets Green Light for Stock Buyback
Adentra Gets Green Light for Stock Buyback
Dec 30, 2024
09:47 AM EST, 12/30/2024 (MT Newswires) -- Adentra ( HDIUF ) said on Monday that the Toronto Stock Exchange has accepted its notice to make a Normal Course Issuer Bid (NCIB). The company may buy back up to 2.4 million shares from Jan. 2 for one year. Adentra ( HDIUF ) did not buy back any shares under its current...
Nvidia Completes Acquisition of Run:ai
Nvidia Completes Acquisition of Run:ai
Dec 30, 2024
09:53 AM EST, 12/30/2024 (MT Newswires) -- Nvidia ( NVDA ) completed its acquisition of AI software company Run:ai, according to a blog post from Run:ai on Monday. Run:ai co-Founders Ronen Dar and Omri Geller said the company plans to open source the Run:ai software to help the community build better AI, faster, which will allow the software to extend...
Copyright 2023-2026 - www.financetom.com All Rights Reserved